Vaccination coverage in Lebanon following the Syrian crisis: results from the district-based immunization coverage evaluation survey 2016

Mansour, Ziad; Hamadeh, Randa; Rady, Alissar; Danovaro-Holliday, M. Carolina; Fahmy, Kamal; Said, Racha; Brandt, Lina; Warrak, Ramy; Ammar, Walid

doi:10.1186/s12889-019-6418-9

Table 5 Crude and adjusted odds ratios for sociodemographic factors associated with full vaccination, Lebanon CES 2016

From: Vaccination coverage in Lebanon following the Syrian crisis: results from the district-based immunization coverage evaluation survey 2016

Sociodemographic factors	Type of Vaccine
	Polio 3		DTP 3		HepB 3		Hib 3		MCV 2		RCV 1
Odds Ratio^a	Crude [95% CI]	Adjusted [95% CI]	Crude [95% CI]	Adjusted [95% CI]	Crude [95% CI]	Adjusted [95% CI]	Crude [95% CI]	Adjusted [95% CI]	Crude [95% CI]	Adjusted [95% CI]	Crude [95% CI]	Adjusted [95% CI]
Nationality
Lebanese[ref]
Syrian	0.5* [0.4–0.6]	0.6* [0.5–0.7]	0.5* [0.4–0.6]	0.6* [0.5–0.8]	0.6* [0.5–0.7]	0.7* [0.5–0.8]	0.5* [0.4–0.6]	0.7* [0.6–0.8]	0.6* [0.5–0.6]	0.7* [0.6–0.8]	0.7* [0.6–0.8]	0.9 [0.7–1.0]
Sex
Male[ref]
Female	0.9 [0.8–1.1]	0.9 [0.8–1.1]	0.9 [0.8–1.1]	1.0 [0.8–1.2]	0.9 [0.8–1.1]	0.9 [0.8–1.1]	1.0 [0.8–1.1]	1.0 [0.9–1.2]	1.0 [0.9–1.1]	1.0 [0.9–1.1]	1.0 [0.9–1.1]	1.0 [0.9–1.1]
Age
12–23 months[ref]
24–35 months	1.2 [1.0–1.5]	1.3* [1.1–1.6]	1.1 [0.9–1.4]	1.2 [0.9–1.5]	0.9 [0.8–1.2]	1.0 [0.8–1.2]	1.1 [0.9–1.3]	1.1 [0.9–1.4]	1.8* [1.6–2.2]	1.9* [1.6–2.2]	1.5* [1.2–1.7]	1.5* [1.3–1.8]
36–47 months	1.2 [0.9–1.5]	1.3* [1.1–1.7]	1.2 [0.9–1.5]	1.3* [1.1–1.7]	1.0 [0.8–1.3]	1.1 [0.9–1.4]	1.1 [0.9–1.4]	1.2 [0.9–1.5]	1.9* [1.6–2.2]	2.1* [1.8–2.5]	1.9* [1.6–2.2]	2.0* [1.7–2.4]
48–59 months	1.4* [1.1–1.8]	1.7* [1.3–2.2]	1.2 [1.0–1.5]	1.5* [1.2–1.9]	1.2 [0.9–1.4]	1.3* [1.1–1.7]	1.1 [0.9–1.4]	1.4* [1.1–1.7]	2.5* [2.1–2.9]	2.9* [2.5–3.5]	2.4* [2.0–2.9]	2.8* [2.3–3.4]
Place of last vaccination
Health facility[ref]
Private clinic	1.4* [1.2–1.7]	1.1 [0.9–1.3]	1.7* [1.4–2.1]	1.3* [1.1–1.6]	1.5* [1.3–1.8]	1.3* [1.1–1.5]	1.9* [1.5–2.3]	1.4* [1.1–1.8]	1.4* [1.2–1.6]	1.1 [0.9–1.3]	1.5* [1.3–1.7]	1.3* [1.1–1.5]
Other	0.7* [0.5–0.9]	0.7* [0.5–0.9]	0.7* [0.5–0.9]	0.7* [0.5–0.9]	0.8* [0.6–0.9]	0.7* [0.5–0.9]	0.8 [0.6–1.1]	0.8 [0.6–1.1]	0.5* [0.4–0.7]	0.5* [0.4–0.6]	0.6* [0.5–0.7]	0.5* [0.4–0.7]
Mothers’ educational status
Doesn’t know how to read and write[ref]
Knows how to read and write	1.4* [1.1–1.9]	1.2 [0.9–1.7]	1.2 [0.9–1.6]	1.0 [0.7–1.4]	1.2 [0.9–1.7]	1.0 [0.7–1.4]	1.4* [1.1–1.8]	1.2 [0.8–1.6]	1.2 [0.9–1.7]	1.2 [0.9–1.6]	1.4* [1.1–1.8]	1.3 [1.0–1.7]
Primary/complementary level	1.9* [1.4–2.6]	1.4* [1.1–1.9]	1.5* [1.1–2.0]	1.0 [0.7–1.4]	1.4* [1.1–2.0]	1.0 [0.7–1.4]	1.7* [1.3–2.3]	1.2 [0.9–1.7]	1.4* [1.1–1.7]	1.2 [0.9–1.5]	1.8* [1.4–2.3]	1.5* [1.2–2.0]
Secondary level	2.7* [2.0–3.7]	1.7* [1.2–2.4]	2.0* [1.5–2.7]	1.1 [0.8–1.6]	1.8* [1.3–2.5]	1.1 [0.8–1.6]	2.5* [1.8–3.5]	1.5* [1.1–2.2]	2.3* [1.7–3.0]	1.7* [1.3–2.4]	2.0* [1.5–2.6]	1.6* [1.2–2.1]
Post-school technical level	1.9* [1.3–2.6]	1.3 [0.9–2.0]	1.9* [1.3–2.7]	1.2 [0.8–1.9]	1.6* [1.1–2.3]	1.0 [0.7–1.6]	1.6* [1.2–2.3]	1.1 [0.8–1.6]	1.8* [1.4–2.3]	1.5* [1.1–1.9]	2.3* [1.7–3.1]	1.9* [1.4–2.6]
University level	2.9* [2.1–4.0]	2.0* [1.4–3.0]	2.9* [2.1–4.1]	1.8* [1.2–2.8]	1.8* [1.3–2.5]	1.1 [0.8–1.6]	3.3* [2.4–4.5]	2.2* [1.5–3.1]	2.3* [1.8–3.0]	1.9* [1.4–2.5]	2.1* [1.7–2.8]	1.7* [1.3–2.2]

*P-values are significant at α = 0.05 level of significance. P-values were based on a t-distribution
^aCrude odds ratios were based on a weighted simple logistic regression of completed vaccination coverage. Adjusted odds ratios were based on a weighted multivariable logistic regression model of completed vaccination coverage accounting for all the variables in the model. Both analyses took into consideration the sampling design and were performed for each vaccine separately

Back to article page

ISSN: 1471-2458

Contact us

Submission enquiries: bmcpublichealth@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Public Health

Contact us